6/24/17
1
Tom Depuydt, ir, PhDHead of Medical Physics
Radiation Oncology department UZ Leuven
and ParTICLe Proton Therapy Center
KU Leuven
Proton Therapy Technology in the Clinic
Scientific Meeting BVS-ABR:
“Proton therapy – From the Need to the Solution”
June 23rd 2017
From radiation physics to a clinical radiotherapy treatment modality
depth
dose
• Protons loose kinetic energy gradually when travelling through matter, through multiple collisions with atomic electrons
• The rate of energy loss or “stopping power” depends on the kinetic energy itself
• Multiple Coulomb interactions with atomic nuclei make protons scatter
• Non-elastic collisions with atomic nucleiknocks out one or more protons, neutrons, or nucleon clusters
Evolution of delivery techniques of the last 20 years
“Dose sculpting hitting the target avoiding other tissues”
Classic Radiotherapy
Highly conformal
Radiotherapy
Proton vs. photontherapy
tumor tumor
Intensity-modulated photon radiotherapy Proton radiotherapy
High therapeutic dose level
Intermediate/lowdose level
No dose
Organ at Risk
Organ at Risk
Photon Proton
No dose
“Proton beams have no exit dose”
No dose
6/24/17
2
?From radiation physics to a clinical radiotherapy treatment modality
depth
dose
“A whole range of technologies is necessary to fully
unleash the potential of proton therapy in the clinic”
“TECHNOLOGY is KEY”
Proton therapy technology in the clinic
• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning
• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation
• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity
Layout of a “typical” PT facility
Fixed beam room
Cyclo vault
Rotating gantry room
Proton beam extracted from cyclotron
depth
dose
Bragg peak
Entrance plateau
Pencil beam
250MeV or 30 cm range
“Cyclotron produces small single high-
energy proton beam of ≈250 MeV”
Few mm width
Small “pencil beam”
6/24/17
3
Passive scattering energy/range modulation• Create from a Bragg peak single
energy proton beam a Spread Out Bragg Peak (SOBP) covering a
volume in depth
• SOBP is a weighted sum of Bragg
peaks
• Range modulator wheels rotate at
high frequencies and “scan” the
Bragg peak fast in depth to create a
SOBP
SOBP modulation
Passive scattering nozzle• Create from a 3 mm diameter s ingle
energy proton beam a wide beam with homogeneous intensity (s imilar to linac system for photons)
• Multiple scatterers in a cascade,
homogenous or constructed from a
combination of rings of high-Z and
low-Z materials to refocus as many
protons as possible into the field
aperture
Passive scattering nozzle
target
SOBP modulation = Cte
Aperture + compensator
• Patient-specific Apertures and range compensators are used to
shape the beam and distal edge depth of the SOBP to the target volume contours
Towards Pencil Beam Scanning …
SOBP modulation = Cte
Target
Limited extra dose
SOBP modulation
6/24/17
4
Scanning magnets for Pencil Beam Scanning (PBS)
F = q(v×B)
F=mv2=qvB
(if v�B)
R
BENDING
Y
X
Energy selection system
E = modified,
thus proton range is changed
Layer/Energy switching
Time=1-2 seconds
-Cyclotron produces single energy (fe. 250 MeV)-”Degrader + Bending magnet + movable slit” to select lower proton beam energy
Degrader
Dos
e
Depth
Energy switching
Scanning
target volume
Proton beam visualized in liquid scintillator solution
Courtesy PSICourtesy PSI
Pencil beam scanning over target volumeMagnetic deflection scanning
Pencil beam scanning spot maps
“Degrees of freedom”:
Spot position (X,Y)
Energy/Layer (Z)
Weight (Dose)
6/24/17
5
Single Field Uniform Dose (SFUD) approach
• Spot map of each treatment field generates
a uniform dose distribution in the target
volume
Intensity modulated proton therapy (IMPT) approach
• Spot map of each treatment field generates
an optimized non-uniform dose distribution
in the target volume
• Only the combination of all treatment field of
the IMPT plan generate the uniform dose yo
the target
• Better sparing of healthy tissue achieved
with IMPT then with SFUD
Clinical PT Delivery technology anno 2017
Passive scattering wide beam (PS)
PS
PBS
• Proven technology (90% PT patients
treated today)
• “Simple” wide beam approach
• Excess dose to normal tissue
• Patient specific collimators and
compensators (labor intensive)
• Significant neutron dose
Pencil beam scanning (PBS)
• More flexible (IMPT)
• No requirement of patient specific
collimators and compensators
• Interplay effects for moving targets
Neutron ambient dose Passive Scattering vs. PBS
Schneider et al. IJROBP 2002
6/24/17
6
Proton therapy technology in the clinic
• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning
• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation
• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity
Range uncertainty issue in proton therapy
The Gare Montparnasse becam e
famous for the derailment on 22
October 1895 of the Granv ille–Par is
Express, whic h overr an the buffer
stop. The engine c areer ed acr oss
almost 30 metres (100 ft) of the
station concours e, crashed through
a 60-centimetre (2 ft) thick wal l, shot
across a terrace and sm ashed out of
the station, plummeting onto the
Place de Rennes 10 metres (33 ft)
below, where it stood on its nose.
Proton range and the train metaphor …
“Protons do stop but there is an uncertainty on where exactly”
Paganetti et al. Phys. Med. Biol. 2012 and Knopf et al. Phys. Med. Biol. 2013
Reducing uncertainties in proton therapy
“3% to 5% proton range uncertainty”
Range uncertainty issue in proton therapy
• ... due to anatomical changes
Paganetti et al. Phys. Med. Biol. 2012 and Knopf et al. Phys. Med. Biol. 2013
6/24/17
7
Proton therapy technology in the clinic
• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning
• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation
• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity
Image guidance in PT
• Historically indications treated with PT were close to bony structures
(cranial, spine, …) which were good natural fiducials for tomor location
• Planar X-ray imaging was the standard up to only a few years ago
Base of skull chordoma
Image guidance in PT
Difference in
particle track history
Range shift
“Example: Filling nasal cavities”
Image guidance in PT: Learning from XT !?
1999: David Jaffray and first CBCT integrated in XT linac
“And the rest is history …”
2016: First CBCT-guided PT
6/24/17
8
Image guidance in PTIntegrated Cone-beam imaging
Dual-source on-board X-ray imaging
In-room image guidance in proton therapy
In-room CT-on-rails
CTPT
CTPT
CTPT CT
Proton therapy technology in the clinic
• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning
• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation
• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity
Range verification in PT: Prompt gamma imaging
• Resulting from inelastic interactions of incident protons and target nuclei
• The nucleus is excited to a higher energy state and emits
a single photon (PG) as it returns to the ground state
• the isotropic PG rays can be detected instantaneously(within a few nanoseconds) following the nuclear
interactions
• Wide energy spectrum, between 0 and 7 MeV
• reasonably high production rate/signal for a typical
therapeutic dose of 2 Gy min−1
• PG are produced along the proton tracks, the path of a
pencil beam within the patient could be imaged as a line source by an adequate gamma camera.
• Real-time online verification method
Moteabbed et al. Phys Med Biol 2011
Slit-design gamma camera (IBA prototype)
Smeets et al. Phys Med Biol 2012
6/24/17
9
Range verification in PT: Prompt gamma imaging
Smeets et al. Phys Med Biol 2012
Range verification in PT: Prompt gamma imaging
Slit cameraNozzle
Deviatio
n p
en
cil b
eam
ran
ge
Patient
Range verification in PT: In-vivo PET imaging
• Inelastic interaction of the proton beam with atomic nuclei create unstable isotopes
• Excited atomic nuclei undergo β+- decay and emit characteristic positrons
• 11C (T1/2 = 20.39 min), 15O (T1/2 = 2.03 min), 13N (T1/2 = 9.97 min), 30P (T1/2 = 2.50
min) and 38K (T1/2 = 7.63 min)
• Annihilation of positrons create a 511 keVgamma pair detectable by the PET scanner coincidence measurement
Moteabbed et al. Phys Med Biol 2011
Range verification in PT: In-vivo PET imaging
6/24/17
10
Range verification in PT: In-vivo PET imaging• No direct correlation with dose distribution
• Agreement with calculations with accuracy of 1-2 mm
• Signal related to local elemental composition of tissues (C,O, …) and activation timing in delivery process (PBS)
• Delay between PT delivery and offline PET read-out (typical 20 min),
resulting in:
o Loss of signal (11C T1/2=20 min, 15OT1/2=2 min)
o Physiological processes (blood perfusion, metabolism) cause biological wash-out (location dependent)
• other patient position PET vs PT, coregistration issues
Moteabbed et al. Phys Med Biol 2011 Parodi et al. Phys Med Biol 2002, 2005, 2007a/b
Sim. PET signal PET signalDose
Range verification in PT: In-vivo PET imaging
Parodi et al. Phys Med Biol 2002, 2005, 2007a/b
Transfer to diagnostic PETIn-room PET
Online PET has less delay (2 min), higher signal, less wash-out, no coregitration issues
Read-out delay (20 min), low signal (mainly 11C), wash-out, coregitration issues with treatment position PT
Proton therapy technology in the clinic
• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning
• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation
• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity
Dual Energy CT imaging for Stopping Power Ratio estimation
• An estimation of Proton Stopping Power
Ratio’s (SPR) based on Single Energy CT
(SECT) has the issue that
materials/tissues with the same CT-number could have a different elementalcomposition, and SPR.
• Conversion of SECT into stopping powerresults in ~3-4% range uncertainty
• Dual energy computed tomography(DECT) can provide simultaneous
estimation of relative electron density ρe
and effective atomic number Zeff.
• Using the Bethe-Bloch formula SPR’s can
be estimated of different tissues based on a
DECT of the patient
Schneider et al. Phys Med Biol 1996
6/24/17
11
Estimation of protonDual Energy CT imaging for Stopping Power Ratio estimation Dual Energy CT imaging for Stopping Power Ratio estimation
Dual-source CT (Siemens) Twinbeam (Siemens)
Au-filter Sn-filter
DECT Technology Overview
Dual Energy CT imaging for Stopping Power Ratio estimation Proton therapy technology in the clinic
• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning
• Technology to manage uncertainties in proton therapyo Image guidanceo Range verificationo Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation
• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity
6/24/17
12
Impact of organ motion on PBS dose delivery
0 1 2 3 4 5 6 7 8 9 100
0.5
1
1.5
2
2.5
Interplay effect between PBS scanned dose delivery and organ motion
Generating high dose region using
multiple pencil beams (spots)
“static” dose
0 1 2 3 4 5 6 7 8 9 100
0.5
1
1.5
2
2.5
Organ motion can change the position of the spots
relative to each other, resulting in hot/cold spots
Dose to a moving target
0 1 2 3 4 5 6 7 8 9 100
0.5
1
1.5
2
2.5
3
Rescanning N-times reduces the interplay effects
and approximately re-established the “static” dose
“static” dose
Dose to moving target
with N-times rescanning
Organ motion management/compensation
Proton therapy technology in the clinic
• Proton therapy delivery technologyo Passive scatteringo Pencil beam scanning
• Technology to manage uncertainties in proton therapyo Image guidanceo Range verification (In-vivo)o Dual-energy CT for Stopping Power Estimationo Organ motion management/compensation
• Proton therapy facilities anno 2017o “Embedded” facilitieso Technology maturity
History of Proton Therapy (PT) facilities
A by-product
“PT facilities evolves from being …”
EmbeddedModality
NUCLEAR
PHYSICS
RESEARCH
FACILITY
PT
Dedicated stand-alonefacility
PT
HOSPITAL
PT
PHYSICS/BIOLOGYRESEAR
CHFACILITY
6/24/17
13
PT Facility size
60x100 meter
“The metaphors in PT …” “Size measure of PT centers … sport field?”
Range uncertainty
“Compact systems as enabling technology for embedding PT… ?”
15x28 meter
11x24 meter
PT Facility size
Impression of finished ParTICLe facility
UZ Leuven campus Gasthuisberg
PT EMBEDDED IN UZ LEUVEN
GASTHUISBERG CAMPUS
R
T
IBA S2C2 superconducting synchrocyclotron IBA Proteus ONE compact gantry beam-line
Scanning magnets
Energy selection
“Compact” PT systems
6/24/17
14
ParTICLe Proton Therapy center in Leuven (Embedded)
Existing Radiation Oncology dept., UZ Leuven
C
Lab Access
PT AClinical
Treatment
room 1
PT BResearch
room (future
clinical 2)
66
m
23
m
Linac 5 XT Linac 4 XT Linac 3 XT Linac 2 XT Linac 1 XT
CT 1
CT 2
PDR BT
HDR BT
PT A
PT A: CLINICAL TREATMENT ROOM
Specifications:-IBA Proteus ONE system
-Compact gantry with 220° rotation
-Patient positioning robot
-1 kHz Pulsed proton beam
-230 MeV maximum energy (32 cm WET)
-70 MeV minimum energy (degraded)
-Field size 20x24 cm (scanning range)
-Spot size in air (100MeV): !<6 mm
-Scanning SAD >3m (X) and >7m (Y)
10-15 "s10 pC
Charge
Time
XT PT
Volumetric image guidance (CBCT only recently introduced in PT)
Adaptive Radiotherapy (Probably more needed in PT)
(revival in XT?)
RT of moving tumors (Issues to solve in PBS, triggers development
of motion management strategies in PBS-only
environments)
(Could/will finds its way to XT) PTV-less robust planning strategies“Classic margin recipies invalid?!”
IMRT (IMPT find its way to mainstream PT)
Concluding remarks …
“Embedded PT facilities, PT becoming main stream and Technological cross-talk between XT and PT”
• AAPM Report 16 (1986), Protocol for heavy charged-particle therapy beam dosimetry, no PBS
• ICRU Report 59 (1998) , Clinical Proton dosimetry, no PBS
• IAEA TRS-398 (2000), The current Code of Practice for proton dosimetry no PBS
• ICRU Report 78 (2007), coverage PBS limited
• IAEA: Update of TRS-398 (<2020?)
• AAPM TG-185: Commissioning of Proton Therapy Systems
• AAPM TG-224: Proton Machine QA
• NCS subcommittee on proton dosimetry
• EPTN ("ESTRO initiative")
• IPEM
“The current activity of different guideline working groups shows that PBS is getting to maturity, but it is not there yet. It also shows that existing guidelines do not meet the current needs.”
Publishes guidelines Guidelines in preparation
International guidelines for PBS PT ?!
Concluding remarks …
6/24/17
15
Concluding remarks …
“Sticking to the train metaphor …”
… is like jumping a moving train
Range uncertainty
Getting trained on PBS PT today ...
Assimilate proton therapy technology/methodology today
ParTICLe
“Particle Therapy Interuniversitary Center Leuven”
Some dates:-End of construction works: Q1 2018
-Delivery PT system: Q1 2018
-Acceptance Testing: Q1 2019
-Clinical commissioning: Q2 2019
-First patient treatment: Q3 2019